A detailed history of Bouvel Investment Partners, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Bouvel Investment Partners, LLC holds 43,882 shares of ADPT stock, worth $286,110. This represents 0.09% of its overall portfolio holdings.

Number of Shares
43,882
Previous 45,880 4.35%
Holding current value
$286,110
Previous $234,000 4.27%
% of portfolio
0.09%
Previous 0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$3.37 - $5.12 $6,733 - $10,229
-1,998 Reduced 4.35%
43,882 $224,000
Q2 2024

Jul 12, 2024

SELL
$2.34 - $3.96 $351 - $594
-150 Reduced 0.33%
45,880 $166,000
Q1 2024

Apr 15, 2024

BUY
$2.88 - $4.8 $2,390 - $3,984
830 Added 1.84%
46,030 $147,000
Q4 2023

Jan 11, 2024

BUY
$3.46 - $5.33 $3,463 - $5,335
1,001 Added 2.26%
45,200 $221,000
Q3 2023

Oct 10, 2023

BUY
$5.07 - $8.44 $1,906 - $3,173
376 Added 0.86%
44,199 $240,000
Q2 2023

Jul 14, 2023

BUY
$6.19 - $8.78 $8,610 - $12,212
1,391 Added 3.28%
43,823 $294,000
Q1 2023

Apr 11, 2023

BUY
$7.8 - $10.11 $9,672 - $12,536
1,240 Added 3.01%
42,432 $374,000
Q4 2022

Jan 18, 2023

BUY
$6.26 - $9.34 $9,602 - $14,327
1,534 Added 3.87%
41,192 $0
Q3 2022

Oct 13, 2022

BUY
$6.5 - $12.67 $163,527 - $318,751
25,158 Added 173.5%
39,658 $282,000
Q2 2022

Jul 13, 2022

BUY
$6.4 - $14.73 $723 - $1,664
113 Added 0.79%
14,500 $117,000
Q1 2022

Apr 11, 2022

BUY
$10.12 - $28.9 $910 - $2,601
90 Added 0.63%
14,387 $200,000
Q4 2021

Jan 19, 2022

SELL
$25.17 - $36.85 $4,354 - $6,375
-173 Reduced 1.2%
14,297 $401,000
Q3 2021

Oct 07, 2021

SELL
$30.02 - $39.87 $7,234 - $9,608
-241 Reduced 1.64%
14,470 $492,000
Q2 2021

Jul 12, 2021

BUY
$32.22 - $44.59 $2,416 - $3,344
75 Added 0.51%
14,711 $601,000
Q1 2021

Apr 16, 2021

SELL
$37.26 - $67.74 $1,751 - $3,183
-47 Reduced 0.32%
14,636 $589,000
Q4 2020

Feb 02, 2021

BUY
$45.01 - $65.47 $660,881 - $961,296
14,683 New
14,683 $868,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $932M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Bouvel Investment Partners, LLC Portfolio

Follow Bouvel Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bouvel Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bouvel Investment Partners, LLC with notifications on news.